(4aR,7aR)-octahydrocyclopenta[b]morpholine

Catalog No. :
ACRHLN146
CAS No. :
1616435-00-7
Molecular Formula :
C7H13NO
Molecular Weight :
127.19

IUPAC Name:(4aR,7aR)-octahydrocyclopenta[b][1,4]oxazine

(4aR,7aR)-octahydrocyclopenta[b]morpholine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$501.00Login to see priceIn stockInquiry
250mg97%$800.00Login to see priceIn stockInquiry
500mg97%$1334.00Login to see priceIn stockInquiry
1g97%$2000.00Login to see priceIn stockInquiry
5g97%$5999.00Login to see priceIn stockInquiry
10g97%$9998.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(4aR,7aR)-octahydrocyclopenta[b]morpholine
IUPAC Name(4aR,7aR)-octahydrocyclopenta[b][1,4]oxazine
MDL No.MFCD28411554
Molecular FormulaC7H13NO
Molecular Weight127.19
SMILES[H][C@]12NCCO[C@]1([H])CCC2
InChI KeyFVHPPCBSLJVBQR-RNFRBKRXSA-N
Synonym1616435-00-7 | (4aR,7aR)-Octahydrocyclopenta[b]morpholine | (4aR,7aR)-octahydrocyclopenta[b][1,4]oxazine | (4aR,7aR)-2,3,4,4a,5,6,7,7a-octahydrocyclopenta[b][1,4]oxazine | SCHEMBL10264157 | MFCD28411554 | (trans)-octahydrocyclopenta[b][1,4]oxazine | CS-00
CAS No.1616435-00-7
PubChem CID28796216

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364

Synthetic Route by SureRoute

1. ACRHLN146 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACRHLN146 route product structure diagram
    ACRHLN1461616435-00-7 In Stock
Inquiry

2. ACRHLN146 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACRHLN146 route product structure diagram
    ACRHLN1461616435-00-7 In Stock
Inquiry

Comments (0)